Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 57 results.
User Information
Export Records
  1. 1.   Heat shock factor 1 (HSF1) specifically potentiates c-MYC-mediated transcription independently of the canonical heat shock response
  2. Xu, Meng; Lin,Ling; Ram,Babul; Shriwas,Omprakash; Chuang, Kun-Han; Dai, Siyuan; Su, Kuo-Hui; Tang, Zijian; Dai,Chengkai
  3. Cell Reports. 2023, May 23; 42(6): 112557.
  1. 2.   MYC assembles and stimulates topoisomerases 1 and 2 in a "topoisome"
  2. Das, Subhendu K.; Kuzin, Vladislav; Cameron, Donald P.; Sanford, Suzanne; Jha, Rajiv Kumar; Nie, Zuqin; Rosello, Marta Trullols; Holewinski,Ronald; Andresson,Thorkell; Wisniewski, Jan; Natsume, Toyoaki; Price, David H.; Lewis, Brian A.; Kouzine, Fedor; Levens, David; Baranello, Laura
  3. Molecular Cell. 2022, Jan 6; 82(1): 140-158. e12.
  1. 3.   Bioinformatic analysis linking genomic defects to chemosensitivity and mechanism of action
  2. Covell,David
  3. PloS one. 2021, Apr 28; 16(4):
  1. 4.   Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex
  2. Calabrese,Dave; Chen,Xiang; Leon, Elena C.; Gaikwad, Snehal M.; Phyo, Zaw; Hewitt, William M.; Alden, Stephanie; Hilimire, Thomas A.; He, Fahu; Michalowski, Aleksandra M.; Simmons, John K.; Saunders, Lindsey B.; Zhang, Shuling; Connors, Daniel; Walters,Kylie; Mock, Beverly A.; Schneekloth,Jay
  3. NATURE COMMUNICATIONS. 2018, Oct 12; 9(1): 4229.
  1. 5.   PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
  2. Gryder, Berkley E.; Yohe, Marielle E.; Chou, Hsien-Chao; Zhang, Xiaohu; Marques, Joana; Wachtel, Marco; Schaefer, Beat; Sen, Nirmalya; Song, Young; Gualtieri, Alberto; Pomella, Silvia; Rota, Rossella; Cleveland, Abigail; Wen, Xinyu; Sindiri, Sivasish; Wei, Jun S.; Barr, Frederic G.; Das, Sudipto; Andresson, Thorkell; Guha, Rajarshi; Lal-Nag, Madhu; Ferrer, Marc; Shern, Jack F.; Zhao, Keji; Thomas, Craig J.; Khan, Javed
  3. Cancer Discovery. 2017, Aug; 7(8): 884-899.
  1. 6.   A New View of Pathway-Driven Drug Resistance in Tumor Proliferation
  2. Nussinov, Ruth; Tsai, Chung-Jung; Jang, Hyunbum
  3. TRENDS IN PHARMACOLOGICAL SCIENCES. 2017, May; 38(5): 427-437.
  1. 7.   Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation
  2. Lee, M. H.; Lahusen, T.; Wang, R. H.; Xiao, C.; Xu, X.; Hwang, Y. S.; He, W. W.; Shi, Y.; Deng, C. X.
  3. Oncogene. 2012, Jan; 31(1): 116-127.
  1. 8.   IKK alpha represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin
  2. Liu, B.; Willette-Brown, J.; Liu, S.; Chen, X.; Fischer, S. M.; Hu, Y.
  3. Cell Death and Differentiation. 2011, Dec; 18(12): 1854-1864.
  1. 9.   Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155
  2. Chang, S. H.; Wang, R. H.; Akagi, K.; Kim, K. A.; Martin, B. K.; Cavallone, L.; Haines, D. C.; Basik, M.; Mai, P.; Poggi, E.; Isaacs, C.; Looi, L. M.; Mun, K. S.; Greene, M. H.; Byers, S. W.; Teo, S. H.; Deng, C. X.; Sharan, S. K.; Kathleen Cuningham Fdn, C.
  3. Nature Medicine. 2011, Oct; 17(10): 1275-U308.
  1. 10.   Large-scale Exploration of Gene-Gene Interactions in Prostate Cancer Using a Multistage Genome-wide Association Study
  2. Ciampa, J.; Yeager, M.; Amundadottir, L.; Jacobs, K.; Kraft, P.; Chung, C.; Wacholder, S.; Yu, K.; Wheeler, W.; Thun, M. J.; Divers, W. R.; Gapstur, S.; Albanes, D.; Virtamo, J.; Weinstein, S.; Giovannucci, E.; Willett, W. C.; Cancel-Tassin, G.; Cussenot, O.; Valeri, A.; Hunter, D.; Hoover, R.; Thomas, G.; Chanock, S.; Chatterjee, N.
  3. Cancer Research. 2011, May; 71(9): 3287-3295.
  1. 11.   Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling
  2. Wei, Q. O.; Jiang, H.; Xiao, Z.; Baker, A.; Young, M. R.; Veenstra, T. D.; Colburn, N. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Apr; 108(17): 7004-7009.
  1. 12.   Tumors Induced in Mice by Direct Inoculation of Plasmid DNA Expressing Both Activated H-ras and c-myc
  2. Sheng-Fowler, L.; Cai, F.; Fu, H. Q.; Zhu, Y.; Orrison, B.; Foseh, G.; Blair, D. G.; Hughes, S. H.; Coffin, J. M.; Lewis, A. M.; Peden, K.
  3. International Journal of Biological Sciences. 2010, Mar 29; 6(2): 151-162.
  1. 13.   Nucleosomal Fluctuations Govern the Transcription Dynamics of RNA Polymerase II
  2. Hodges, C.; Bintu, L.; Lubkowska, L.; Kashlev, M.; Bustamante, C.
  3. Science. 2009 325(5940): 626-628.
  1. 14.   Cdk2 and Cdk4 Activities Are Dispensable for Tumorigenesis Caused by the Loss of p53
  2. Padmakumar, V. C.; Aleem, E.; Berthet, C.; Hilton, M. B.; Kaldis, P.
  3. Molecular and Cellular Biology. 2009 29(10): 2582-2593.
  1. 15.   Recruitment of a SAP18-HDAC1 Complex into HIV-1 Virions and Its Requirement for Viral Replication
  2. Sorin, M.; Cano, J.; Das, S.; Mathew, S.; Wu, X. H.; Davies, K. P.; Shi, X. L.; Cheng, S.; Ott, D.; Kalpana, G. V.
  3. Plos Pathogens. 2009 5(6):
  1. 16.   Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay
  2. Yang, X. Y.; Chen, E. Y.; Jiang, H. G.; Muszynski, K.; Harris, R. D.; Giardina, S. L.; Gromeier, M.; Mitra, G.; Soman, G.
  3. Journal of Virological Methods. 2009, Jan; 155(1): 44-54.
  1. 17.   Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk
  2. Berndt, S. I.; Potter, J. D.; Hazra, A.; Yeager, M.; Thomas, G.; Makar, K. W.; Welch, R.; Cross, A. J.; Huang, W. Y.; Schoen, R. E.; Giovannucci, E.; Chan, A. T.; Chanock, S. J.; Peters, U.; Hunter, D. J.; Hayes, R. B.
  3. Human Molecular Genetics. 2008 17(17): 2665-2672.
  1. 18.   The identification of microRNAs in a genomically unstable region of human chromosome 8q24
  2. Huppi, K.; Volfovsky, N.; Runfola, T.; Jones, T. L.; Macklewicz, M.; Martin, S. E.; Mushinski, J. F.; Stephens, R.; Caplen, N. J.
  3. Molecular Cancer Research. 2008 6(2): 212-221.
  1. 19.   Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas
  2. Chen, M.; Rahman, L.; Voeller, D.; Kastanos, E.; Yang, S. X.; Feigenbaum, L.; Allegra, C.; Kaye, F. J.; Steeg, P.; Zajac-Kaye, M.
  3. Oncogene. 2007, Jul; 26(33): 4817-4824.
  1. 20.   Post-transcriptional control of the interferon system
  2. Khabar, K. S. A.; Young, H. A.
  3. Biochimie. 2007, Jun-Jul; 89(6-7): 761-769.
  1. 21.   Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2
  2. Yang, Y. A.; Zhang, G. M.; Feigenbaum, L.; Zhang, Y. E.
  3. Cancer Cell. 2006, Jun; 9(6): 445-457.
  1. 22.   CDK2 is required by MYC to induce apoptosis
  2. Deb-Basu, D.; Aleem, E.; Kaldis, P.; Felsher, D. W.
  3. Cell Cycle. 2006, Jun; 5(12): 1342-1347.
  1. 23.   Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure
  2. Liu, J.; Xie, Y. X.; Ducharme, D. M. K.; Shen, J.; Diwan, B. A.; Merrick, B. A.; Grissom, S. F.; Tucker, C. J.; Paules, R. S.; Tennant, R.; Waalkes, M. P.
  3. Environmental Health Perspectives. 2006, MAR; 114(3): 404-411.
  1. 24.   C-MYC induces KIR expression via a novel control region upstream of the conventional adult KIR promoter
  2. Haack, B.; McCullar, V.; Lenvik, T.; Pitt, M.; Anderson, S.; Miller, J. S.
  3. Blood. 2005, NOV 16; 106(11, Part 1): 225A, Abstract 764-226A, Abstract 764.
  1. 25.   Retinoic acid-induced downmodulation of telomerase activity in human cancer cells
  2. Xiao, X. D.; Sidorov, I. A.; Gee, J.; Lempicki, R. A.; Dimitrov, D. S.
  3. Experimental and Molecular Pathology. 2005, OCT; 79(2): 108-117.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel